Phenoxymethylpenicillin: Clinical Evidence & Trials
Phenoxymethylpenicillin is a penicillin antibiotic used to treat a wide range of bacterial infections including respiratory, skin, and urinary tract infections.
Penicillins have decades of evidence as first-line agents for streptococcal, pneumococcal, and other susceptible bacterial infections.
Evidence Strength
Level A (Strong) for group A streptococcal pharyngitis, community-acquired pneumonia (susceptible strains), MSSA skin infections, and UTI.
Key Clinical Trial Findings
- •Rheumatic fever prevention — penicillin prophylaxis reduces recurrent streptococcal pharyngitis and subsequent acute rheumatic fever by >80%; WHO recommends benzylpenicillin secondary prophylaxis
- •Cochrane 2013 (pharyngitis) — penicillin reduces symptom duration by ~1 day vs placebo; primary benefit is rheumatic fever prevention in endemic areas
- •BTS/NICE community pneumonia — amoxicillin recommended first-line for low-severity CAP; comparable efficacy to fluoroquinolones with lower resistance selection pressure
- •MRSA and beta-lactamase producers — flucloxacillin remains first-line for MSSA skin infections; >90% clinical success
- •UTI — amoxicillin-clavulanate achieves >85% eradication in susceptible E. coli strains
Numbers Needed to Treat (NNT)
Streptococcal pharyngitis (1+ day symptom relief): NNT ≈ 6. Rheumatic fever prevention with secondary prophylaxis: NNT ≈ 4. SSTI with flucloxacillin vs placebo: NNT ≈ 3.
Guideline Recommendations
NICE/PHE: amoxicillin designated ACCESS antibiotic (first-choice, use broadly). Flucloxacillin first-choice for MSSA skin infections. Benzylpenicillin IV first-choice for meningococcal disease. Piperacillin-tazobactam designated WATCH antibiotic (use only for serious infections).
Conditions Treated with Phenoxymethylpenicillin
Questions about your medication?
Our AI Symptom Checker analyses your symptoms and suggests the most likely diagnoses — including relevant medications.
Use AI Symptom Checker →